Key terms
About AUGX
Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. It offers live support including referrals, orders, and reminders that allow clinicians to focus on patient care. The company was founded by Ian Shakil in 2012 and is headquartered in San Francisco, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest AUGX news
Apr 09
9:00am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Apr 04
8:45am ET
Lake Street Reaffirms Their Buy Rating on Augmedix (AUGX)
Apr 04
7:05am ET
Augmedix and SADA in partnership to scale ambient documentation, no terms
Apr 03
8:48am ET
Augmedix resumed with a Buy at B. Riley
Mar 20
7:45am ET
Augmedix: A Strong Buy on Positive Earnings, Growth Prospects, and Strategic Partnerships
Mar 19
9:00am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Mar 19
8:43am ET
Augmedix price target lowered to $4.50 from $6.50 at Evercore ISI
Mar 19
8:00am ET
Augmedix price target lowered to $5 from $6.50 at Maxim
Mar 19
6:45am ET
Benchmark Co. Keeps Their Buy Rating on Augmedix (AUGX)
Mar 18
4:05pm ET
Augmedix sees FY24 revenue $60M-$62M, consensus $61.53M
Mar 18
4:04pm ET
Augmedix reports Q4 EPS (9c), consensus (10c)
Mar 12
7:25am ET
Augmedix announces data, product enhancements for Augmedix Go
Feb 12
7:11am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Envista Holdings (NVST), Augmedix (AUGX) and Cochlear Limited (OtherCHEOF)
No recent press releases are available for AUGX
AUGX Financials
Key terms
Ad Feedback
AUGX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
AUGX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
